In a recent update, ObsEva, a leading biopharmaceutical company focused on women s reproductive health, announced changes to its Board of Directors. These developments, along with a subsequent court ruling, have significant implications for the company s future operations.ObsEva revealed that effective immediately, three new members have joined its Board of Directors. These individuals bring a wealth of experience and expertise in various areas such as finance, global business development, and regulatory affairs. The addition of these highly accomplished professionals reflects the company s commitment to strengthen its leadership team and drive strategic decision-making in the rapidly evolving biopharmaceuti...

OBSV's Stock Performance relative to it's Customers

OBSV's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Obseva Sa	7.62	20.11	-58.38	-
SUBTOTAL	0.00	0.00	0.00	-

Sources: Obseva Sa’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Obseva Sa’s corporate clients.
For your research, we’ve provided 9 tables on Obseva Sa corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.